risperidone has been researched along with piperidines in 267 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (3.00) | 18.7374 |
| 1990's | 186 (69.66) | 18.2507 |
| 2000's | 41 (15.36) | 29.6817 |
| 2010's | 28 (10.49) | 24.3611 |
| 2020's | 4 (1.50) | 2.80 |
| Authors | Studies |
|---|---|
| Lindström, E; von Knorring, L | 4 |
| Heykants, J; Lorreyne, W; Van Rompaey, F; Woestenborghs, R | 1 |
| Awouters, FH; Janssen, PA; Meert, TF; Megens, AA; Niemegeers, CJ; Schellekens, KH | 1 |
| Awouters, FH; Megens, AA; Niemegeers, CJ | 2 |
| Gommeren, W; Janssen, PA; Janssen, PM; Leysen, JE; Pauwels, PJ; Wynants, J | 1 |
| Bollen, J; Claus, A; De Cuyper, H; Eneman, M; Heylen, S; Malfroid, M; Peuskens, J | 1 |
| Baert, AL; Bollen, J; Claus, A; De Cuyper, H; Eneman, M; Heylen, S; Malfroid, M; Peuskens, J; Van Ongeval, C; Wilms, G | 1 |
| Gelders, YG; Heylen, SL | 1 |
| Müller-Spahn, F | 1 |
| Marder, SR | 1 |
| Bowden, CR; De Coster, R; Heykants, J; Voina, SJ; Woestenborghs, R | 1 |
| Borison, RL; Diamond, BI; Meibach, RC; Pathiraja, AP | 1 |
| Benkert, O; Hillert, A; Maier, W; Wetzel, H | 1 |
| Awouters, F; Janssen, PA; Megens, AA; Niemegeers, CJ | 1 |
| Gelders, YG; Heylen, SL; Janssen, PA; Reyntjens, AJ; Vanden Bussche, G | 1 |
| Bogdanov, MB; Gaĭnetdinov, RR; Kudrin, VS; Medvedev, OS; Val'dman, AV | 1 |
| Gerlach, J | 1 |
| Kissling, W; Möller, HJ; Pelzer, E; Riehl, T; Wernicke, T | 1 |
| Awouters, F; Janssen, PA; Meert, TF; Megens, AA; Niemegeers, CJ; Schellekens, KH | 1 |
| de Chaffoy de Courcelles, D; Eens, A; Gommeren, W; Janssen, PA; Leysen, JE; Stoof, JC | 1 |
| de Haes, P; Janssen, PA; Meert, TF | 1 |
| Burton, P; Gelders, Y; Heylen, S; Mesotten, F; Pietquin, M; Suy, E | 1 |
| Gelders, YG | 1 |
| de Bruyckere, K; Janssen, PF; Leysen, JE; Schotte, A | 1 |
| Dugovic, C; Janssen, PA; Wauquier, A | 1 |
| Kerwin, R | 1 |
| Jeffries, JJ | 1 |
| MacEwan, GW | 1 |
| Ereshefsky, L; Lacombe, S | 1 |
| Arnott, W; Chouinard, G | 1 |
| Remington, GJ | 2 |
| Kane, JM | 4 |
| Busatto, GF; Costa, DC; Ell, PJ; Kerwin, RW; Pilowsky, LS; Verhoeff, NP | 2 |
| Livingston, MG | 1 |
| Ciccocioppo, R; Massi, M; Panocka, I; Pompei, P | 1 |
| Fensbo, C; Høyberg, OJ; Lingjaerde, O; Remvig, J; Salvesen, I; Sloth-Nielsen, M | 1 |
| Heinrich, K; Hruschka, H; Kinzler, E; Klieser, E; Lehmann, E | 1 |
| Janssen, PF; Leysen, JE; Megens, AA; Schotte, A | 1 |
| Czyrak, A; Frankiewicz, T; Maj, J; Rogóz, Z; Skuza, G | 1 |
| Aghajanian, GK; Gellman, RL | 1 |
| Kerwin, RW | 1 |
| Alessandria, A; Bonifati, V; Giustini, P; Meco, G | 1 |
| Marder, SR; Meibach, RC | 1 |
| Awouters, FH; Janssen, PA | 1 |
| Kido, H; Mori, H; Sakamoto, H; Shiba, K; Sumiyoshi, T; Suzuki, K; Urasaki, K; Yamaguchi, N; Yokogawa, K | 1 |
| Davidson, JE; Mosqueda, RA | 1 |
| Edwards, JG | 1 |
| Dalby, JT; Dickson, R; Williams, R | 1 |
| Emes, CE; Millson, RC | 1 |
| Land, W; Salzman, C | 1 |
| Littrell, K; Schultz, RE | 1 |
| Jahnová, E | 1 |
| Dwight, MM; Keck, PE; McElroy, SL; Stanton, SP; Strakowski, SM | 1 |
| Mok, H; Yatham, LN | 1 |
| Heykants, J; Huang, ML; Mannens, G; Meuldermans, W; Snoeck, E; Van Beijsterveldt, L; Van Peer, A; Woestenborghs, R | 1 |
| McEvoy, JP | 1 |
| Schooler, NR | 1 |
| Owens, DG | 1 |
| Janssen, PM; Leysen, JE; Megens, AA; Schotte, A | 1 |
| Ford, B; Greene, P; Lynch, T | 1 |
| Goodman, WK; McDougle, CJ; Price, LH | 1 |
| Sussman, N | 1 |
| Catalan, J; Singh, AN | 1 |
| Webster, P; Wijeratne, C | 1 |
| Honer, WG; Kopala, L | 1 |
| Goldberg, TE; Weinberger, DR | 1 |
| Cozza, SJ; Edison, DL | 1 |
| Aschauer, H; Kasper, S; Stamenkovic, M | 1 |
| Finlayson, R; Jones, BD; Labelle, A; Purdon, SE | 1 |
| Jones, BD; Labelle, A; Lit, W; Purdon, SE | 1 |
| Fitton, A; Grant, S | 1 |
| Eilers, R | 1 |
| Elomaa, E; Raitasuo, V; Vataja, R | 1 |
| Brammer, M; Bullmore, E; David, A; Howard, R; Mellers, J; Williams, S; Woodruff, P | 1 |
| Bennett, JA; Keck, PE; Wallhausser, LJ | 1 |
| Bennie, EH | 1 |
| Adams, M; Remington, G | 1 |
| Brocco, M; Millan, MJ; Schreiber, R | 1 |
| Eriksson, B; Eriksson, L; Farde, L; Halldin, C; Nyberg, S | 1 |
| Janssen, PM; Leysen, JE; Luyten, WH; Megens, AA; Schotte, A | 1 |
| Borison, RL; Diamond, B; Meibach, RC; Pathiraja, A | 1 |
| Post, L | 1 |
| Bruggeman, R; van der Linden, C; van Woerkom, TC | 1 |
| Geerts, RJ; Heykants, JJ; Leysen, JE; Megens, AA; Meuldermans, WE; van Beijsterveldt, LE; Van den Eynde, HM | 1 |
| Awouters, FH; Dugovic, C; Leysen, JE; Meert, TF; Megens, AA; Niemegeers, CJ; Schotte, A | 1 |
| Beaudry, P; Bélanger, MC; Chouinard, G; Miller, R; Roy, JY; Turnier, L; Vainer, JL | 1 |
| Perrault, G; Sanger, DJ | 1 |
| Auchus, AP; Freeman, A; Green, RC | 1 |
| Heykants, J; Mannens, G; Meuldermans, W; Snoeck, E | 1 |
| Furukawa, H; Hasegawa, T; Kitaichi, K; Nabeshima, T; Yamada, K | 1 |
| Furukawa, H; Hasegawa, T; Kitaichi, K; Nabeshima, T; Ogita, K; Yamada, K; Yoneda, Y | 1 |
| Keegan, D | 1 |
| Villeneuve, A | 1 |
| Sigmundson, HK | 1 |
| Holt, L; O'Croinin, F; Zibin, T | 1 |
| Lee, MA; Meltzer, HY; Ranjan, R | 1 |
| Black, DW; Gupta, S; Smith, DA | 1 |
| Honer, WG; Kopala, LC | 1 |
| Clarke, DE; Yaeger, SF | 1 |
| Bryois, C | 1 |
| Ericsson, B; Farde, L; Halldin, C; Nakashima, Y; Nyberg, S; Oxenstierna, G | 1 |
| Borison, RL | 1 |
| Chouinard, G | 1 |
| Heinrich, K; Kinzler, E; Klieser, E; Lehmann, E; Wurthmann, C | 1 |
| Tavares, AR | 1 |
| DeVane, CL | 1 |
| Love, RC | 1 |
| Perry, PJ | 1 |
| Curtis, VA; Kerwin, RW | 1 |
| Breier, A | 1 |
| Sternlicht, HC; Wells, SR | 1 |
| Pickar, D | 1 |
| Borison, RL; Chouinard, G; Möller, HJ; Müller, H; Schooler, NR | 1 |
| McEvoy, JP; Price, WA; Swanson, CL | 1 |
| Byerly, MJ; Evans, DL; Greer, RA | 1 |
| Silva, JA; Smith, EA; Tekell, JL | 1 |
| Giakas, WJ | 1 |
| Zimbroff, DL | 1 |
| Dalby, JT; Dickson, RA; Edwards, AL; Williams, R | 1 |
| Pelonero, AL | 1 |
| Allen, RL; D'Ath, PJ; Katona, CL; Walker, Z | 1 |
| Price, PL | 1 |
| Möller, HJ | 1 |
| Lindenmayer, JP | 1 |
| Azorin, JM | 1 |
| Aubert, AC; Baumann, P; Bondolfi, G; Meylan, C | 1 |
| Farde, L; Hall, H; Halldin, C; Nyberg, S; Sedvall, G | 1 |
| Shulman, LM; Singer, C; Weiner, WJ | 1 |
| He, H; Richardson, JS | 1 |
| McCarthy, RH; Terkelsen, KG | 1 |
| Huttunen, MO; Larmo, I; Nyholm, R; Piepponen, T; Raitasuo, V; Rantanen, H | 1 |
| Allen, M; Field, K; Ganguli, R; Reddy, R; Tanner, TB | 1 |
| Dave, M | 1 |
| Boland, RJ; Richards, C; Singer, S | 1 |
| Alderman, CP; Fraser, CD | 1 |
| Davis, YB; Jeanblanc, W | 1 |
| Cott, J; Lieberman, JA; Matthews, S; Shore, D | 1 |
| Borison, RL; Brown, TM; Radford, JM | 1 |
| Kirisci, L; Musser, WS | 1 |
| Goss, JB | 1 |
| Houle, S; Kapur, S; Remington, G; Wilson, AA; Zipursky, RB | 1 |
| Fras, I; Major, LF | 1 |
| Jerkovich, GS; Lacey, RL; Preskorn, SH | 1 |
| Devane, CL; Risch, SC; Tyson, SC | 1 |
| Ballard, CG; Harrison, RW; McKeith, IG | 1 |
| Benvenga, MJ; Leander, JD | 1 |
| Cardoni, AA | 1 |
| Peuskens, J | 1 |
| Jacobsen, FM | 1 |
| Goodnick, PJ | 1 |
| Kane, JM; McGlashan, TH | 1 |
| Dahl, ML; Halldin, C; Nyberg, S | 1 |
| Conway, PG; Corbett, R; Cornfeldt, M; Rush, DK; Strupczewski, JT; Szewczak, MR; Wilmot, CA | 1 |
| Buttiëns, M; Dierick, G; Geutjens, J; Heylen, S; Sieben, G; Thiry, P; Vanden Borre, R; Vermote, R | 1 |
| Addington, D; Arnott, W; Beauclair, L; Bloom, D; Chouinard, G; Jones, B; Labelle, A; MacEwan, GW; Remington, G | 1 |
| Massi, M; Panocka, I; Pompei, P | 1 |
| Koyama, T; Kusumi, I; Matsubara, R; Matsubara, S; Yamashita, I | 1 |
| Remr, J | 1 |
| Jahnová, E; Keleová, A; Nyulassy, S | 1 |
| Conway, PC; Corbett, R; Dunn, RW; Hartman, H; Helsley, GC; Kerman, LL; Strupczewski, JT; Woods, AT | 1 |
| Edouard, S; Le Moing, JP; Levron, JC | 1 |
| Hayakawa, H; Kawai, K; Kikumoto, O; Motohashi, N; Okamoto, Y; Yamawaki, S; Yokota, N | 1 |
| Matsubara, R | 1 |
| Menkes, DB | 1 |
| Aravagiri, M; Marder, SR; Midha, KK; Van Putten, T | 1 |
| Assié, MB; Koek, W; Sleight, AJ | 1 |
| De Coster, R; Heykants, J; Huang, ML; Jansen, AA; Jonkman, JH; Van Peer, A; Visscher, HW; Woestenborghs, R; Zylicz, Z | 1 |
| Czyrak, A; Jaros, T; Maj, J; Moryl, E | 1 |
| Kang, DY; Kim, CE; Min, SK; Rhee, CS | 1 |
| Bigg, DC; Koek, W; Sleight, AJ | 1 |
| Czobor, P; Volavka, J | 1 |
| Cesková, E; Svestka, J | 1 |
| Brenner, C; Brown, K; Hamburg, EL; Leffler, S; Levy, H | 1 |
| Fischer, TR; Hitchcock, JM; Lister, S; Wettstein, JG | 1 |
| Dashevsky, BA; Frank, RA; Grocki, S; Kehne, JH; Schmidt, CJ; Sorensen, SM; Tsibulsky, VL | 1 |
| Ancill, RJ; Geizer, M | 1 |
| Burke, WJ; Keller, BK; Magnuson, TM | 1 |
| Acton, PD; Busatto, GF; Costa, DC; Ell, PJ; Gacinovic, S; Kerwin, RW; Mertens, J; Mulligan, R; Pilowsky, LS; Terrière, D; Travis, MJ | 1 |
| Bakshi, VP; Geyer, MA; Varty, GB | 1 |
| Alsayegh, L; Backstrom, JR; Berry, SA; Friedman, L; Roth, BL; Sanders-Bush, E; Willins, DL | 1 |
| Ichikawa, J; Meltzer, HY | 1 |
| Baik, J; Han, IW; Koo, MS; Kwak, YT | 1 |
| Chaki, S; Funakoshi, T; Kameo, K; Kawashima, N; Okuyama, S; Omura, T | 1 |
| Carlsson, A; Carlsson, ML; Nilsson, M; Waters, N; Waters, S | 1 |
| Ehmann, TS; Khanbhai, I; MacEwan, GW; Wrixon, C | 1 |
| Arnt, J; Didriksen, M; Pouzet, B | 1 |
| Adler, DN; Brenner, G; Davis, KL; Friedman, JI; Harvey, PD; Howanitz, E; Parrella, M; Temporini, H; White, L | 1 |
| Bar, F; Baruch, Y; Rabey, JM; Strous, RD; Stryjer, R | 1 |
| Albert, MJ; Baldessarini, RJ; Centorrino, F; Kelleher, JP | 1 |
| Chaki, S; Funakoshi, T; Hirota, S; Kameo, K; Takamori, K | 1 |
| Cherry, D; Cummings, JL; Frank, JC; Hewett, L; Kemp, B; Kohatsu, ND; Mittman, B | 1 |
| Lin, SK; Liu, HC; Sung, SM | 1 |
| Chaki, S; Funakoshi, T; Goto, M; Kameo, K; Kawashima, N; Kumagai, T; Nakazato, A; Okuyama, S; Suzuki, Y; Yoshikawa, R | 1 |
| Chaki, S; Funakoshi, T; Kawashima, N; Komurasaki, T; Kumagai, T; Nakazato, A; Ogawa, S; Okuyama, S; Suzuki, Y | 1 |
| Kalkman, HO; Loetscher, E | 1 |
| Jia, X; Parier, JL; Pesco-Koplowitz, L; Xie, C; Zhao, Q | 1 |
| Hori, K; Inada, T; Oda, T; Tominaga, I | 1 |
| Freeman, MP; Gelenberg, AJ; Gnanadesikan, M | 1 |
| Avery, M; Fermini, B; Fossa, AA; Raunig, DL; Wang, E; Wisialowski, T; Wolfgang, E | 1 |
| Browman, KE; Curzon, P; Decker, MW; Fox, GB; Hancock, AA; Komater, VA; Rueter, LE | 1 |
| Cullen, EI; Khan, A; Kumar, D; Perdomo, CA; Pratt, RD; Preskorn, SH; Reyes, JF | 1 |
| Arya, P; Butler, R; Warner, J | 1 |
| Burris, KD; Kikuchi, T; Miwa, T; Mori, T; Stark, A; Tadori, Y; Tottori, K | 1 |
| Ballard, ME; Cowart, M; Decker, MW; Esbenshade, TA; Faghih, R; Fox, GB; Hancock, AA; Pan, L; Roberts, S; Rueter, LE; Zhang, M | 1 |
| Bastianetto, S; Danik, M; Mennicken, F; Quirion, R; Williams, S | 1 |
| Didriksen, M; Kreilgaard, M; Olsen, CK | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Mishima, K; Mizuki, A; Nagai, H; Nishimura, R; Ogata, A; Sano, K; Shoyama, Y | 1 |
| Duaso, E; Formiga, F; Fort, I; Pérez-Castejón, JM; Riu, S; Ruiz, D | 1 |
| DeVane, CL; Horner, MD; Markowitz, JS; McGurk, SR; Nahas, Z; Palecko, S; Risch, SC | 1 |
| Freudenreich, O; Goff, DC; Green, MF; Johnson, SA; Lamberti, JS; Leon, AC; Manschreck, T; Miller, AL; Patel, J | 1 |
| Anderson, GT; Barido, R; Bonhaus, DW; Brann, MR; Brunmark, P; Davis, RE; Dyssegaard, A; Gardell, LR; Hacksell, U; Johnson, RW; Pounds, L; Tabatabaei, A; Vanover, KE; Veinbergs, I | 1 |
| Barzó, P; Janka, Z; Kálmán, J; Sas, K; Szakács, R | 1 |
| Ago, Y; Baba, A; Hashimoto, H; Kawasaki, T; Koda, K; Matsuda, T | 1 |
| Diamant, L; Gaisler-Salomon, I; Rubin, C; Weiner, I | 1 |
| Bogetto, F; Marino, F; Montemagni, C; Perrone, D; Rocca, P | 1 |
| Athey, R; Forlano, R; Singh, D | 1 |
| Borg, C; Convers, P; Desmales, S; Laurent, B; Thomas Antérion, C | 1 |
| Abbasi, SH; Akhondzadeh, S; Gerami, M; Ghoreishi, A; Karamghadiri, N; Noroozian, M; Rezazadeh, SA | 1 |
| Kumar, R; Sachdev, PS | 1 |
| Arnt, J; Mørk, A; Witten, LM | 1 |
| Bahk, WM; Cho, HS; Jeon, YW; Jon, DI; Jung, HY; Kim, CH; Kim, HC; Kim, SH; Kim, YH; Kim, YK; Kwon, JS; Lee, SH; Lee, SY; Yang, J; Yi, JS; Yoon, BH | 1 |
| Akama, F; Andoh, H; Kato, K; Matsumoto, H; Sakaguchi, T; Sato, R | 1 |
| Hamaguchi, T; Motomura, E; Nakagawa, M; Ohoyama, K; Okada, M; Shiroyama, T; Tanii, H; Yamamura, S | 1 |
| Bullich, S; Burgess, C; Catafau, AM; Gray, F; Merlo-Pich, E; Nucci, G | 1 |
| Conley, RR; Fijal, BA; Hoffmann, VP; Houston, JP; Kinon, BJ; Stauffer, VL; Witte, MM; Zhao, F | 1 |
| Jardemark, K; Malmerfelt, A; Marcus, MM; Shahid, M; Svensson, TH | 1 |
| Citrome, L; Hochfeld, M; Meng, X; Stahl, SM | 1 |
| Knoepflmacher, D; Shapley, L; Turner, EH | 1 |
| Fossa, AA; Jeyaraj, D; Rosenbaum, DS; Said, TH; Wilson, LD | 1 |
| Haga, T; Hashizume, T; Inoue, T; Katsumata, T; Ogawa, Y; Osada, K; Sogame, Y; Tagawa, M; Taguchi, A; Watanabe, T; Yabuki, M; Yamaguchi, N | 1 |
| Elkis, H; Hacksell, U; Meltzer, HY; Peters, P; van Kammen, DP; Vanover, K; Weiner, DM | 1 |
| Fijał, K; Nikiforuk, A; Popik, P | 1 |
| Alva, G; Brams, M; Citrome, L; Glick, ID; Hochfeld, M; Jackson, R; Kianifard, F; Mattingly, G; Meng, X; Pestreich, L; Weiden, PJ; Winseck, A | 1 |
| Miki, T; Mizuki, Y; Takaki, M | 1 |
| Amodeo, DA; Jones, JH; Ragozzino, ME; Sweeney, JA | 1 |
| Fukui, K; Fukushima, T; Hakariya, H; Ichiba, H; Iwasa, S; Shishikura, M; Yorita, K; Yoshio, T | 1 |
| Karamihalev, S; Prickaerts, J; van Goethem, NP | 1 |
| Morrissette, DA; Stahl, SM | 1 |
| Alva, G; Citrome, L; Glick, ID; Jackson, R; Kianifard, F; Mattingly, G; Meng, X; Weiden, PJ; Winseck, A | 1 |
| Mizuki, Y; Takaki, M | 1 |
| Boettger, S; Jellestad, L; Jenewein, J; Stocker, L | 1 |
| Baba, S; Enomoto, T; Ikeda, K; Murai, T; Nakako, T; Ono, M; Shimizu, I | 1 |
| Aracil-Fernández, A; Berbel, P; Manzanares, J; Navarrete, F; Navarro, D; Ortega-Álvaro, A | 1 |
| Huang, LQ; Li, P; Li, YP; Liu, Y; Pan, X; Yang, Y; Yin, Y; Zhao, ZQ; Zhao, ZX; Zhuang, J | 1 |
| Grayson, B; Harte, MK; Marsh, S; McLean, SL; Neill, JC; Zarroug, SH | 1 |
| Gu, N; Li, H; Li, J; Li, K; Li, L; Liu, C; Luo, X; Qi, S; Shi, J; Wang, C; Wang, L; Wang, Q; Yang, F; Yao, C; Zhang, H | 1 |
| Ensom, MHH; Johnson, EG; Johnson, HE; Wilby, KJ | 1 |
| Alemany-González, M; Chanovas, J; Delgado-Sallent, C; Gener, T; Nebot, P; Puig, MV; Tauste Campo, A | 1 |
| Harvey, PD; Miura, S; Nakamura, H | 1 |
| Lei, L; Li, H; Li, Y; Shen, Y; Yu, W; Yu, Y | 1 |
| Crippa, A; Davis, JM; Leucht, S; Orsini, N; Patel, MX; Siafis, S | 1 |
| Chen, J; Chen, Y; Gao, L; Hao, C; Jin, J; Liu, BF; Liu, X; Ma, R; Wu, Q; Zhang, G; Zheng, L | 1 |
44 review(s) available for risperidone and piperidines
| Article | Year |
|---|---|
New antipsychotics: classification, efficacy, and adverse effects.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride | 1991 |
Ethical issues in drug selection for schizophrenia.
Topics: Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Ethics, Medical; Humans; Informed Consent; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 1993 |
New antipsychotic medications: do research results relate to clinical practice?
Topics: Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Dyskinesia, Drug-Induced; Humans; Isoxazoles; Neurologic Examination; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1993 |
Pharmacological profile of risperidone.
Topics: Antipsychotic Agents; Brain; Dose-Response Relationship, Drug; Haloperidol; Humans; Isoxazoles; Metabolic Clearance Rate; Piperidines; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology | 1993 |
Clinical review of risperidone.
Topics: Antipsychotic Agents; Clinical Trials, Phase III as Topic; Humans; Isoxazoles; Multicenter Studies as Topic; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 1993 |
Clinical considerations in the use of risperidone.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1993 |
Newer antipsychotic drugs. A review of their pharmacology and therapeutic potential.
Topics: Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Piperidines; Remoxipride; Risperidone; Schizophrenia; Treatment Outcome | 1993 |
Risperidone.
Topics: Antipsychotic Agents; Drug Interactions; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1994 |
The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.
Topics: Antipsychotic Agents; Brain; Clozapine; Dyskinesia, Drug-Induced; Extrapyramidal Tracts; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Risperidone: clinical issues in treatment.
Topics: Antipsychotic Agents; Drug Approval; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1994 |
Extrapyramidal side effects and tolerability of risperidone: a review.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Dystonia; Haloperidol; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1994 |
Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Clozapine; Dopamine Antagonists; Drug Therapy, Combination; Female; Fluvoxamine; Haloperidol; Humans; Isoxazoles; Male; Obsessive-Compulsive Disorder; Piperidines; Risperidone; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tic Disorders; Tourette Syndrome | 1994 |
The potential benefits of serotonin receptor-specific agents.
Topics: Antidepressive Agents; Buspirone; Depressive Disorder; Humans; Isoxazoles; Ondansetron; Piperazines; Piperidines; Receptors, Serotonin; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Sumatriptan; Triazoles | 1994 |
The effects of clozapine on neurocognition: an overview.
Topics: Clozapine; Cognition; Cognition Disorders; Dopamine; Humans; Isoxazoles; Neuropsychological Tests; Piperidines; Receptors, Dopamine; Receptors, Muscarinic; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1994 |
Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.
Topics: Absorption; Adult; Aged; Aging; Animals; Antipsychotic Agents; Central Nervous System; Cross-Over Studies; Disease Models, Animal; Drug Interactions; Hemodynamics; Humans; Isoxazoles; Neurosecretory Systems; Piperidines; Risperidone; Schizophrenia; Synaptic Transmission; Tissue Distribution | 1994 |
Survey on the pharmacodynamics of the new antipsychotic risperidone.
Topics: Animals; Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Risperidone; Serotonin Antagonists | 1994 |
Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug.
Topics: Antipsychotic Agents; Brain; Clinical Trials as Topic; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Pathophysiology and treatment of negative symptoms.
Topics: Antipsychotic Agents; Brain; Depression; Dose-Response Relationship, Drug; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Pharmacotherapy of schizophrenia: a review.
Topics: Antipsychotic Agents; Brain; Clozapine; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Recent advances in the pharmacotherapy of schizophrenia.
Topics: Adult; Antipsychotic Agents; Brain; Clozapine; Dopamine; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1994 |
Risperidone: review of its pharmacology and therapeutic use in schizophrenia.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Humans; Isoxazoles; Piperidines; Placebos; Risperidone; Schizophrenia; Treatment Outcome | 1994 |
[New psychopharmacologic alternatives in treatment of schizophrenia].
Topics: Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Isoxazoles; Piperidines; Psychotropic Drugs; Remoxipride; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics.
Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Dopamine Antagonists; Humans; Imidazoles; Indoles; Isoxazoles; Olanzapine; Piperidines; Pirenzepine; Risperidone; Schizophrenia; Serotonin Antagonists | 1995 |
Brief comparison of the pharmacokinetics and pharmacodynamics of the traditional and newer antipsychotic drugs.
Topics: Antipsychotic Agents; Chlorpromazine; Clozapine; Haloperidol; Humans; Isoxazoles; Piperidines; Risperidone; Time Factors | 1995 |
Clinical use of the newer antipsychotic drugs.
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Female; Formularies as Topic; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia | 1995 |
A risk-benefit assessment of risperidone in schizophrenia.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Risk; Risperidone; Schizophrenia | 1995 |
Serotonin, schizophrenia and antipsychotic drug action.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Humans; Isoxazoles; Piperazines; Piperidines; Risperidone; Schizophrenia; Serotonin; Tryptophan | 1995 |
Prospects for pharmacotherapy of schizophrenia.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia | 1995 |
The negative component in schizophrenia.
Topics: Affective Symptoms; Antipsychotic Agents; Haloperidol; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Risperidone; Schizophrenia; Schizophrenic Psychology | 1995 |
New pharmacotherapeutic modalities for negative symptoms in psychosis.
Topics: Affective Symptoms; Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Risperidone; Schizophrenia; Schizophrenic Psychology; Syndrome | 1995 |
Long-term treatment of mood disorders in schizophrenia.
Topics: Affective Symptoms; Antidepressive Agents; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Isoxazoles; Lithium; Long-Term Care; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1995 |
Principal components and further possibilities with the PANSS.
Topics: Affective Symptoms; Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Risperidone; Schizophrenia; Schizophrenic Psychology; Syndrome | 1995 |
Antipsychotic medication in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1995 |
A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors.
Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Humans; Isoxazoles; Piperidines; Risperidone; Serotonin Antagonists | 1995 |
Risperidone: review and assessment of its role in the treatment of schizophrenia.
Topics: Antipsychotic Agents; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1995 |
Treatment of schizophrenia.
Topics: Antipsychotic Agents; Behavior Therapy; Clozapine; Cognitive Behavioral Therapy; Family Therapy; Humans; Isoxazoles; Piperidines; Psychotherapy; Rehabilitation, Vocational; Risperidone; Schizophrenia | 1995 |
Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clinical Trials as Topic; Clozapine; Dosage Forms; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2002 |
Guidelines for managing Alzheimer's disease: Part II. Treatment.
Topics: Advance Directives; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Disease Progression; Donepezil; Humans; Indans; Lorazepam; Patient Education as Topic; Phenylcarbamates; Piperidines; Risperidone; Rivastigmine | 2002 |
Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Calcium Channel Blockers; Carbamazepine; Clozapine; Cyclohexanecarboxylic Acids; Dibenzothiazepines; Donepezil; Fatty Acids, Omega-3; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Indans; Lamotrigine; Lithium Carbonate; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Risperidone; Thiazoles; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2003 |
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
Akathisia and second-generation antipsychotic drugs.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles | 2009 |
Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Dibenzocycloheptenes; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Impulsive Behavior; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Thiazoles; Violence | 2014 |
Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Evidence-Based Medicine; Humans; Olanzapine; Parkinson Disease; Piperazines; Piperidines; Practice Guidelines as Topic; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Urea | 2017 |
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Aripiprazole; Clozapine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Haloperidol; Humans; Imidazoles; Indoles; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Schizophrenic Psychology; Thiazoles; Thiophenes | 2020 |
55 trial(s) available for risperidone and piperidines
| Article | Year |
|---|---|
The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability.
Topics: Antipsychotic Agents; Chronic Disease; Cross-Cultural Comparison; Double-Blind Method; Haloperidol; Humans; Isoxazoles; Observer Variation; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Risperidone; Schizophrenia; Schizophrenic Psychology; Sweden | 1992 |
Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Female; Haloperidol; Hospitalization; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1992 |
Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients.
Topics: Adult; Aged; Antipsychotic Agents; Brain; Cerebral Ventricles; Chronic Disease; Dilatation, Pathologic; Double-Blind Method; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Tomography, X-Ray Computed | 1992 |
Risperidone, a new antipsychotic with serotonin 5-HT2 and dopamine D2 antagonistic properties.
Topics: Antipsychotic Agents; Dopamine Antagonists; Double-Blind Method; Electrocardiography; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine D2; Risperidone; Schizophrenia; Serotonin Antagonists | 1992 |
Risperidone in the treatment of chronic schizophrenic patients: an international double-blind parallel-group study versus haloperidol. The International Risperidone Research Group.
Topics: Antipsychotic Agents; Double-Blind Method; Haloperidol; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1992 |
Risperidone: clinical development: north American results.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Humans; Isoxazoles; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 1992 |
Risperidone: clinical safety and efficacy in schizophrenia.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 1992 |
Pilot clinical investigation of risperidone in the treatment of psychotic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Evaluation; Female; Humans; Isoxazoles; Male; Middle Aged; Pilot Projects; Piperidines; Psychotic Disorders; Risperidone | 1990 |
New antipsychotics: classification, efficacy, and adverse effects.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Receptors, Glutamate; Receptors, Neurotransmitter; Receptors, Serotonin; Remoxipride; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride | 1991 |
Thymosthenic agents, a novel approach in the treatment of schizophrenia.
Topics: Brain; Butyrophenones; Humans; Isoxazoles; Piperidines; Pyrimidinones; Randomized Controlled Trials as Topic; Receptors, Serotonin; Risperidone; Ritanserin; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists | 1989 |
Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Denmark; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Norway; Parkinson Disease, Secondary; Perphenazine; Piperidines; Prevalence; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index | 1993 |
Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: a double blind, randomized trial.
Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Double-Blind Method; Electrocardiography; Electroencephalography; Female; Humans; Infant, Newborn; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia, Paranoid | 1994 |
Risperidone in the treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Placebos; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1994 |
Symptoms in schizophrenic syndromes in relation to age, sex, duration of illness and number of previous hospitalizations.
Topics: Adult; Age Factors; Age of Onset; Aged; Antipsychotic Agents; Female; Haloperidol; Hospitalization; Hospitals, Psychiatric; Humans; Isoxazoles; Male; Middle Aged; Patient Admission; Piperidines; Risperidone; Ritanserin; Schizophrenia; Schizophrenic Psychology; Sex Factors | 1994 |
Efficacy of risperidone on positive features of schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Haloperidol; Humans; Isoxazoles; Piperidines; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Treatment Outcome | 1994 |
Negative symptoms in schizophrenia: assessment of the effect of risperidone.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia; Single-Blind Method | 1994 |
Changes in single symptoms and separate factors of the schizophrenic syndrome after treatment with risperidone or haloperidol.
Topics: Double-Blind Method; Haloperidol; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1994 |
Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.
Topics: Absorption; Adult; Aged; Aging; Animals; Antipsychotic Agents; Central Nervous System; Cross-Over Studies; Disease Models, Animal; Drug Interactions; Hemodynamics; Humans; Isoxazoles; Neurosecretory Systems; Piperidines; Risperidone; Schizophrenia; Synaptic Transmission; Tissue Distribution | 1994 |
Desmopressin for risperidone-induced enuresis.
Topics: Administration, Intranasal; Adult; Antipsychotic Agents; Deamino Arginine Vasopressin; Double-Blind Method; Enuresis; Female; Haloperidol; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone.
Topics: Adult; Antipsychotic Agents; Brain Chemistry; Cerebellum; Cerebral Cortex; Dopamine Antagonists; Humans; Isoxazoles; Male; Piperidines; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Tomography, Emission-Computed | 1993 |
Pharmacokinetics of risperidone in chronic schizophrenic patients.
Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Cross-Over Studies; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia; Therapeutic Equivalency | 1994 |
Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Resistance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Risperidone; Schizophrenia; Schizophrenic Psychology; Sex Characteristics | 1994 |
Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Benzamides; Cerebral Cortex; Dopamine D2 Receptor Antagonists; Female; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Isoxazoles; Male; Middle Aged; Neostriatum; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Remoxipride; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon | 1995 |
Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia | 1995 |
Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Clozapine; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1995 |
A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Haloperidol; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1995 |
The negative component in schizophrenia.
Topics: Affective Symptoms; Antipsychotic Agents; Haloperidol; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Risperidone; Schizophrenia; Schizophrenic Psychology | 1995 |
New pharmacotherapeutic modalities for negative symptoms in psychosis.
Topics: Affective Symptoms; Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Psychometrics; Risperidone; Schizophrenia; Schizophrenic Psychology; Syndrome | 1995 |
Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Clopenthixol; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1995 |
Critique of the Canadian Multicenter Placebo-Controlled Study of Risperidone and Haloperidol.
Topics: Canada; Double-Blind Method; Haloperidol; Humans; Isoxazoles; Piperidines; Research Design; Risperidone; Schizophrenia | 1995 |
Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Humans; Isoxazoles; Male; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1995 |
Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome | 1995 |
A PET study of D2 and 5-HT2 receptor occupancy induced by risperidone in poor metabolizers of debrisoquin and risperidone.
Topics: Adult; Antipsychotic Agents; Debrisoquin; Genotype; Humans; Isoxazoles; Male; Piperidines; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Tomography, Emission-Computed | 1995 |
Risperidone as add-on therapy in behavioural disturbances in mental retardation: a double-blind placebo-controlled cross-over study.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Isoxazoles; Male; Mental Disorders; Middle Aged; Piperidines; Placebos; Risperidone | 1993 |
A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Neurologic Examination; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 1993 |
Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: a parallel group double-blind comparative trial.
Topics: Adolescent; Adult; Chronic Disease; Double-Blind Method; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia | 1993 |
Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Dominance, Cerebral; Dose-Response Relationship, Drug; Double-Blind Method; Electroencephalography; Evoked Potentials; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology; Social Behavior | 1993 |
Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Female; Haloperidol; Humans; Isoxazoles; Male; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 1993 |
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Cognition Disorders; Donepezil; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 2002 |
Pharmacokinetic and safety assessments of concurrent administration of risperidone and donepezil.
Topics: Adult; Area Under Curve; Biological Availability; Cross-Over Studies; Donepezil; Drug Interactions; Humans; Indans; Male; Piperidines; Risperidone | 2003 |
Concurrent administration of donepezil HCl and risperidone in patients with schizophrenia: assessment of pharmacokinetic changes and safety following multiple oral doses.
Topics: Administration, Oral; Adult; Aged; Antipsychotic Agents; Area Under Curve; Cholinesterase Inhibitors; Donepezil; Drug Combinations; Drug Interactions; Humans; Indans; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia | 2004 |
Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Clozapine; Cross-Over Studies; Donepezil; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Indans; Male; Middle Aged; Nootropic Agents; Olanzapine; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2007 |
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition Disorders; Dioxoles; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Pilot Projects; Piperidines; Psychiatric Status Rating Scales; Psychomotor Performance; Risperidone; Sample Size; Schizophrenia; Schizophrenic Psychology | 2008 |
A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Donepezil; Double-Blind Method; Female; Humans; Indans; Male; Mental Status Schedule; Neuropsychological Tests; Nootropic Agents; Piperidines; Prospective Studies; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2008 |
Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Piperazines; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Weight Gain; Young Adult | 2010 |
Contribution of SPECT measurements of D2 and 5-HT2A occupancy to the clinical development of the antipsychotic SB-773812.
Topics: Adult; Algorithms; Antipsychotic Agents; Brain; Cohort Studies; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Humans; Image Processing, Computer-Assisted; Iodobenzenes; Male; Piperidines; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed, Single-Photon; Young Adult | 2011 |
Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidone.
Topics: Adult; Antipsychotic Agents; Apoptosis Regulatory Proteins; Benzodiazepines; Biomarkers, Pharmacological; Black or African American; Drug Resistance; Genotype; Humans; Isoxazoles; Membrane Proteins; Membrane Transport Proteins; Olanzapine; Piperidines; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptors, AMPA; Risperidone; Schizophrenia; White People | 2012 |
Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperazines; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult | 2012 |
Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2mg/day, but does not enhance efficacy of haloperidol, 2mg/day: comparison with reference dose risperidone, 6mg/day.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Time Factors; Urea; Young Adult | 2012 |
A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Aortic Bodies; Aripiprazole; Benzodiazepines; Cohort Studies; Drug Administration Schedule; Drug Substitution; Female; Humans; Isoxazoles; Male; Middle Aged; Olanzapine; Piperazines; Piperidines; Psychiatric Status Rating Scales; Quinolones; Risperidone; Schizophrenia; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2014 |
Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophrenia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dizziness; Female; Humans; Isoxazoles; Male; Olanzapine; Piperazines; Piperidines; Quinolones; Risperidone; Schizophrenia; Treatment Outcome | 2015 |
Low-Dose Atypical Antipsychotic Risperidone Improves the 5-Year Outcome in Alzheimer's Disease Patients with Sleep Disturbances.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Caregivers; Donepezil; Female; Humans; Hypnotics and Sedatives; Indans; Male; Melatonin; Neuropsychological Tests; Nootropic Agents; Nursing Homes; Piperidines; Polysomnography; Pyridines; Risperidone; Sleep Wake Disorders; Treatment Outcome; Zolpidem | 2015 |
Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Asian People; China; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Piperidines; Prolactin; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome; Weight Gain; Young Adult | 2015 |
Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Japan; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Piperidines; Risperidone; Schizophrenia | 2020 |
Model-based analysis of therapeutic efficacy of blonanserin and risperidone in schizophrenia patients and effects on prolactin: A randomized double-blind study.
Topics: Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Models, Statistical; Piperazines; Piperidines; Prolactin; Risperidone; Schizophrenia; Sex Factors; Young Adult | 2020 |
172 other study(ies) available for risperidone and piperidines
| Article | Year |
|---|---|
Determination of risperidone and 9-hydroxyrisperidone in plasma, urine and animal tissues by high-performance liquid chromatography.
Topics: Animals; Calibration; Chromatography, High Pressure Liquid; Isoxazoles; Paliperidone Palmitate; Piperidines; Pyrimidines; Quality Control; Reproducibility of Results; Risperidone; Spectrophotometry, Ultraviolet | 1992 |
Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
Topics: Animals; Antiemetics; Antipsychotic Agents; Apomorphine; Behavior, Animal; Body Temperature; Dogs; Dopamine Agents; Dopamine Antagonists; Eating; Female; Haloperidol; Isoxazoles; Lethal Dose 50; Locomotion; Male; Mice; Motor Activity; Muscles; Neurotransmitter Agents; Piperidines; Posture; Pyrimidinones; Rats; Rats, Inbred Strains; Risperidone; Ritanserin; Serotonin; Serotonin Antagonists; Synaptic Transmission | 1992 |
Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
Topics: Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Isoxazoles; Male; Motor Activity; Piperidines; Pyrimidinones; Rats; Rats, Inbred Strains; Risperidone | 1992 |
In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
Topics: Animals; Antipsychotic Agents; Biogenic Monoamines; Brain; Female; Haloperidol; In Vitro Techniques; Isoxazoles; Male; Neurotransmitter Agents; Piperidines; Pyrimidinones; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Risperidone; Spiperone; Tissue Distribution | 1992 |
Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro.
Topics: Animals; Antipsychotic Agents; Cells, Cultured; Haloperidol; Isoxazoles; Ketanserin; Male; Piperidines; Pituitary Gland; Prolactin; Rats; Rats, Inbred Strains; Risperidone; Spiro Compounds; Stimulation, Chemical | 1992 |
Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.
Topics: Adult; Aged; Antipsychotic Agents; Depressive Disorder; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Syndrome | 1992 |
Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
Topics: Animals; Antipsychotic Agents; Apomorphine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Injections, Intravenous; Isoxazoles; Male; Piperidines; Rats; Rats, Inbred Strains; Risperidone; Ritanserin; Seizures; Serotonin; Serotonin Antagonists; Synaptic Transmission; Tryptamines | 1990 |
[Study by the intracerebral microdialysis method of the effects of atypical neuroleptics and anxiolytics on striatal release and metabolism of dopamine in awake rats].
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Brain Chemistry; Buspirone; Corpus Striatum; Dialysis; Dopamine; In Vitro Techniques; Isoxazoles; Male; Methoxydimethyltryptamines; Piperidines; Rats; Rats, Inbred Strains; Risperidone; Ritanserin; Sulpiride; Wakefulness | 1991 |
Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
Topics: Acute Disease; Adult; Antipsychotic Agents; Chronic Disease; Female; Humans; Isoxazoles; Male; Middle Aged; Pilot Projects; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 1991 |
Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Conditioning, Psychological; Dogs; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Isoxazoles; Male; Motor Activity; Oxazoles; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Risperidone; Serotonin Antagonists | 1988 |
Biochemical profile of risperidone, a new antipsychotic.
Topics: Animals; Antipsychotic Agents; Blood Platelets; Cerebral Cortex; Dopamine; Ergolines; Female; Haloperidol; Isoxazoles; Models, Molecular; Norepinephrine; Oxazoles; Phosphatidic Acids; Piperidines; Quinpirole; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Ritanserin; X-Ray Diffraction | 1988 |
Differential effects of the new antipsychotic risperidone on large and small motor movements in rats: a comparison with haloperidol.
Topics: Animals; Antipsychotic Agents; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Motor Activity; Oxazoles; Piperidines; Rats; Rats, Inbred Strains; Risperidone | 1988 |
Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats.
Topics: Animals; Discrimination, Psychological; Dose-Response Relationship, Drug; Generalization, Stimulus; Isoxazoles; Lysergic Acid Diethylamide; Male; Oxazoles; Piperidines; Rats; Rats, Inbred Strains; Risperidone | 1989 |
Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients.
Topics: Adult; Aged; Antipsychotic Agents; Blood Pressure; Electrocardiography; Female; Hormones; Humans; Isoxazoles; Male; Middle Aged; Oxazoles; Piperidines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone | 1989 |
Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography.
Topics: Animals; Brain; Dopamine Antagonists; Isoxazoles; Male; Oxazoles; Piperidines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Ritanserin; Serotonin Antagonists | 1989 |
Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat.
Topics: Animals; Antipsychotic Agents; Isoxazoles; Male; Oxazoles; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Sleep; Wakefulness | 1989 |
Adverse reaction reporting and new antipsychotics.
Topics: Agranulocytosis; Anemia, Aplastic; Antipsychotic Agents; Clozapine; Drug Monitoring; Humans; Isoxazoles; Neutropenia; Piperidines; Remoxipride; Risperidone; Schizophrenia | 1993 |
Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone.
Topics: Adult; Antipsychotic Agents; Benzamides; Brain; Brain Mapping; Contrast Media; Dopamine D2 Receptor Antagonists; Humans; Iodine Radioisotopes; Isoxazoles; Male; Piperidines; Psychiatric Status Rating Scales; Pyrrolidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon | 1993 |
Risperidone and remoxipride for schizophrenia.
Topics: Antipsychotic Agents; Female; Humans; Isoxazoles; Piperidines; Remoxipride; Risperidone; Schizophrenia | 1993 |
5-HT2 receptor antagonists do not reduce ethanol preference in Sardinian alcohol-preferring (sP) rats.
Topics: Alcohol Drinking; Animals; Antipsychotic Agents; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Risperidone; Ritanserin; Serotonin Antagonists | 1993 |
Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
Topics: Animals; Antipsychotic Agents; Apomorphine; Autoradiography; Behavior, Animal; Clozapine; Guinea Pigs; Haloperidol; In Vitro Techniques; Iodine Radioisotopes; Isoxazoles; Male; Mescaline; Piperidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Neurotransmitter; Receptors, Serotonin; Risperidone; Stereotyped Behavior | 1993 |
Risperidone for chronic schizophrenia.
Topics: Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1994 |
Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Behavior, Animal; Body Temperature; Clozapine; Dibenzothiepins; Exploratory Behavior; Haloperidol; Isoxazoles; Male; Mice; Motor Activity; Piperazines; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Serotonin Receptor Agonists | 1994 |
Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs.
Topics: Action Potentials; Animals; Antipsychotic Agents; Bicuculline; Cerebral Cortex; Chlorpromazine; Clozapine; Electrophysiology; gamma-Aminobutyric Acid; Haloperidol; In Vitro Techniques; Interneurons; Isoxazoles; Male; Membrane Potentials; Piperidines; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin Antagonists | 1994 |
Risperidone for hallucinations in levodopa-treated Parkinson's disease patients.
Topics: Aged; Antipsychotic Agents; Hallucinations; Humans; Isoxazoles; Levodopa; Parkinson Disease; Piperidines; Risperidone | 1994 |
Risperidone.
Topics: Adult; Clinical Trials as Topic; Humans; Isoxazoles; Multicenter Studies as Topic; Piperidines; Placebos; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1994 |
Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
Topics: Amphetamine; Animals; Antipsychotic Agents; Apomorphine; Butyrophenones; Dogs; Dopamine D2 Receptor Antagonists; Haloperidol; Humans; In Vitro Techniques; Isoxazoles; Lysergic Acid Diethylamide; Motor Activity; Neostriatum; Oxygen Consumption; Piperidines; Rats; Risperidone; Schizophrenia; Serotonin Antagonists; Species Specificity; Tryptamines | 1994 |
In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol.
Topics: Animals; Antipsychotic Agents; Benzamides; Brain; Cerebellum; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; In Vitro Techniques; Isoxazoles; Ketanserin; Ligands; Male; Neostriatum; Piperidines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone | 1994 |
Schizophrenia.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1994 |
Risperidone for schizophrenia.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1994 |
Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
Topics: Adult; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Dystonia; Humans; Isoxazoles; Male; Neurologic Examination; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome | 1994 |
New antipsychotic agent, risperidone, introduced.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychotic Disorders; Risperidone | 1994 |
Risperidone-induced priapism.
Topics: Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Humans; Isoxazoles; Lithium Carbonate; Lorazepam; Male; Middle Aged; Piperidines; Priapism; Risperidone; Schizophrenia, Paranoid | 1994 |
Risperidone: a novel antipsychotic medication.
Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
New drug offers hope for people with schizophrenia.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
The effect of risperidone and ritanserin on human IgG and IgM synthesis in vitro.
Topics: Antipsychotic Agents; B-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin G; Immunoglobulin M; In Vitro Techniques; Isoxazoles; Monocytes; Piperidines; Pokeweed Mitogens; Risperidone; Ritanserin; Schizophrenia | 1994 |
Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder.
Topics: Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Humans; Isoxazoles; Piperidines; Risperidone | 1994 |
Response to clozapine as a predictor of risperidone response in schizophrenia.
Topics: Adult; Antipsychotic Agents; Clozapine; Female; Humans; Isoxazoles; Piperidines; Receptors, Dopamine; Risperidone; Schizophrenia; Treatment Outcome | 1994 |
The pharmacokinetics of risperidone in humans: a summary.
Topics: Aged; Animals; Antipsychotic Agents; Biotransformation; Dogs; Half-Life; Humans; Isoxazoles; Liver Cirrhosis; Male; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Reference Values; Renal Insufficiency; Risperidone; Schizophrenia | 1994 |
Risperidone: new horizons for the schizophrenic patient. 9th World Congress of Psychiatry of the World Psychiatric Association, Rio de Janeiro, June 1993.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1994 |
Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity.
Topics: Animals; Antipsychotic Agents; Brain; Clone Cells; Clozapine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Guinea Pigs; Haloperidol; Humans; Isoxazoles; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Serotonin Antagonists | 1994 |
Risperidone in Parkinson's disease.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Parkinson Disease; Piperidines; Psychotic Disorders; Risperidone | 1994 |
Risperidone in HIV-related manic psychosis.
Topics: AIDS Dementia Complex; Antipsychotic Agents; Bipolar Disorder; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone | 1994 |
Risperidone-induced neuroleptic malignant syndrome.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; Piperidines; Risperidone | 1994 |
Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia.
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Fluvoxamine; Humans; Isoxazoles; Male; Obsessive-Compulsive Disorder; Piperidines; Receptors, Serotonin; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin | 1994 |
FDA approved new drug bulletin: risperidone (risperdal).
Topics: Adult; Antipsychotic Agents; Child; Drug Interactions; Female; Humans; Isoxazoles; Patient Education as Topic; Piperidines; Pregnancy; Risperidone | 1994 |
Risperidone in adolescents.
Topics: Adolescent; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hospitalization; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Risperidone for Tourette's syndrome.
Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Piperidines; Risperidone; Severity of Illness Index; Tourette Syndrome | 1994 |
Risperidone treatment for severe negative symptoms.
Topics: Adult; Antipsychotic Agents; Clonazepam; Depressive Disorder; Drug Therapy, Combination; Humans; Isoxazoles; Male; Patient Readmission; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Risperidone in the treatment of pervasive developmental disorder.
Topics: Adolescent; Adult; Antipsychotic Agents; Autistic Disorder; Child; Child Development Disorders, Pervasive; Follow-Up Studies; Humans; Intellectual Disability; Isoxazoles; Male; Neuropsychological Tests; Piperidines; Risperidone; Serotonin; Stereotyped Behavior | 1994 |
Risperidone's cost.
Topics: Antipsychotic Agents; Delivery of Health Care; Health Services Accessibility; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1994 |
Risperidone-induced neuroleptic malignant syndrome in young patient.
Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; Piperidines; Risperidone | 1994 |
Cortical response to exogenous visual stimulation during visual hallucinations.
Topics: Aged; Antipsychotic Agents; Dementia; Evoked Potentials, Visual; Hallucinations; Humans; Isoxazoles; Magnetic Resonance Imaging; Male; Piperidines; Risperidone; Visual Cortex | 1995 |
High-dose antipsychotic medication.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Risperidone and obsessive-compulsive symptoms.
Topics: Antipsychotic Agents; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Isoxazoles; Lithium Carbonate; Male; Middle Aged; Neurologic Examination; Obsessive-Compulsive Disorder; Pimozide; Piperidines; Recurrence; Risperidone | 1994 |
Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone.
Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Fluorobenzenes; Isoxazoles; Male; Motor Activity; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Risperidone; Serotonin Antagonists | 1994 |
Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.
Topics: Animals; Antipsychotic Agents; Autoradiography; Clozapine; Haloperidol; In Vitro Techniques; Isoxazoles; Male; Piperidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Neurotransmitter; Receptors, Serotonin; Risperidone | 1993 |
Risperidone.
Topics: Adolescent; Adult; Antipsychotic Agents; Community Mental Health Services; Humans; Isoxazoles; Mental Disorders; Piperidines; Risperidone | 1994 |
Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone.
Topics: Adult; Antipsychotic Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isoxazoles; Male; Middle Aged; Neurologic Examination; Pilot Projects; Piperidines; Risperidone; Serotonin Antagonists; Tourette Syndrome | 1994 |
Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat.
Topics: Animals; Antiemetics; Antipsychotic Agents; Apomorphine; Brain; Dogs; Half-Life; Injections, Subcutaneous; Isoxazoles; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Organ Size; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Rats, Wistar; Receptors, Neurotransmitter; Risperidone; Spectrophotometry, Ultraviolet; Tryptamines | 1994 |
Effects of typical and atypical antipsychotic drugs on response decrement patterns in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Conditioning, Operant; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Rats, Wistar; Remoxipride; Risperidone; Serotonin Antagonists; Sulpiride | 1995 |
Agitated behavior relieved following treatment of cervical dystonia in dementia.
Topics: Alzheimer Disease; Botulinum Toxins; Chlorpromazine; Dystonia; Female; Humans; Isoxazoles; Middle Aged; Neck Muscles; Phenytoin; Piperidines; Risperidone; Valproic Acid | 1995 |
Plasma protein binding of risperidone and its distribution in blood.
Topics: Adult; Aged; Animals; Antipsychotic Agents; Blood Cells; Blood Proteins; Dogs; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Isoxazoles; Kidney Diseases; Liver Diseases; Male; Middle Aged; Orosomucoid; Paliperidone Palmitate; Piperidines; Protein Binding; Pyrimidines; Rats; Rats, Wistar; Risperidone; Serum Albumin | 1994 |
Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Frontal Lobe; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraperitoneal; Isoxazoles; Locomotion; Male; Phencyclidine; Piperidines; Random Allocation; Rats; Rats, Wistar; Risperidone; Ritanserin; Schizophrenia; Serotonin; Stereotyped Behavior | 1994 |
Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine.
Topics: Animals; Antipsychotic Agents; Dizocilpine Maleate; Drug Tolerance; Haloperidol; Isoxazoles; Male; Methamphetamine; Motor Activity; Phencyclidine; Piperidines; Rats; Rats, Wistar; Receptors, Phencyclidine; Receptors, Serotonin; Risperidone; Ritanserin | 1995 |
Novel neuroleptics in schizophrenia: theory and clinical relevance.
Topics: Antipsychotic Agents; Brain; Clozapine; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Re: Hypomania associated with risperidone.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Chronic Disease; Female; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia, Paranoid | 1995 |
Schizophrenia and severe tardive dyskinesia responsive to risperidone.
Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Isoxazoles; Neurologic Examination; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1994 |
Addressing emerging social needs of patients treated with new neuroleptics.
Topics: Adult; Antipsychotic Agents; Clozapine; Female; Humans; Isoxazoles; Male; Middle Aged; Nursing Assessment; Piperidines; Psychiatric Nursing; Risperidone; Schizophrenia; Socialization | 1994 |
Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Binding Sites; Brain; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Schizophrenia; Tomography, Emission-Computed | 1995 |
Risperidone in Parkinson's disease.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Parkinson Disease; Piperidines; Risperidone | 1995 |
Recent developments in antipsychotic therapy. Introduction.
Topics: Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1995 |
Risperidone in childhood schizophrenia.
Topics: Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Drug Therapy, Combination; Humans; Isoxazoles; Male; Methylphenidate; Piperidines; Risperidone; Schizophrenia; Treatment Outcome | 1995 |
Effects of concomitant risperidone and lithium treatment.
Topics: Antipsychotic Agents; Confusion; Creatine Kinase; Drug Therapy, Combination; Fever; Humans; Isoxazoles; Lithium Carbonate; Neuroleptic Malignant Syndrome; Piperidines; Risperidone; Schizophrenia | 1995 |
Behavioral stimulation associated with risperidone initiation.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Anxiety; Benzodiazepines; Confusion; Female; Humans; Isoxazoles; Middle Aged; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome | 1995 |
Prolonged erection associated with risperidone treatment.
Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Piperidines; Priapism; Psychotic Disorders; Risperidone | 1995 |
Risperidone treatment for a Tourette's disorder patient with comorbid obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Fluoxetine; Humans; Isoxazoles; Male; Obsessive-Compulsive Disorder; Piperidines; Risperidone; Tourette Syndrome; Treatment Outcome | 1995 |
Switching patients from clozapine to risperidone therapy.
Topics: Antipsychotic Agents; Clonazepam; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Isoxazoles; Lorazepam; Piperidines; Risperidone; Schizophrenia; Substance Withdrawal Syndrome | 1995 |
Risperidone-induced prolactin elevations in premenopausal women with schizophrenia.
Topics: Antipsychotic Agents; Female; Humans; Hyperprolactinemia; Isoxazoles; Piperidines; Premenopause; Prolactin; Risperidone; Schizophrenia | 1995 |
Prescribing risperidone.
Topics: Antipsychotic Agents; Cost-Benefit Analysis; Drug Prescriptions; Financing, Government; Health Care Rationing; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Virginia | 1995 |
Risperidone for psychotic and behavioural symptoms in Lewy body dementia.
Topics: Aged; Antipsychotic Agents; Dementia; Female; Humans; Isoxazoles; Male; Piperidines; Risperidone | 1995 |
Risperidone for the treatment of schizophrenia: does it have a niche?
Topics: Dopamine Antagonists; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology | 1995 |
Reversible neutropenia during a cold: possible involvement of risperidone? A case report.
Topics: Adult; Antipsychotic Agents; Cold Temperature; Female; Humans; Influenza, Human; Isoxazoles; Neutropenia; Piperidines; Risperidone; Schizophrenia | 1995 |
Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study.
Topics: Adult; Antipsychotic Agents; Autopsy; Autoradiography; Binding Sites; Brain; Clozapine; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone | 1995 |
Risperidone in Gilles de la Tourette syndrome.
Topics: Antipsychotic Agents; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone; Tourette Syndrome | 1995 |
Risperidone augmentation of clozapine.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone; Schizophrenia, Paranoid; Schizophrenic Psychology | 1995 |
Risperidone for treatment-refractory schizophrenia.
Topics: Adult; Antipsychotic Agents; Humans; Isoxazoles; Male; Piperidines; Risperidone; Schizophrenia; Treatment Outcome | 1995 |
Two cases of risperidone-induced neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Female; Humans; Isoxazoles; Neuroleptic Malignant Syndrome; Piperidines; Primidone; Psychotic Disorders; Risperidone; Tremor | 1995 |
Two cases of risperidone-induced neuroleptic malignant syndrome.
Topics: Aged; Antipsychotic Agents; Humans; Isoxazoles; Male; Neuroleptic Malignant Syndrome; Piperidines; Risperidone; Schizophrenia, Paranoid | 1995 |
Use of risperidone with a patient sensitive to conventional neuroleptic drugs.
Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Isoxazoles; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperidines; Risperidone; Treatment Outcome | 1995 |
Risperidone for treating dementia-associated aggression.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Dementia; Dementia, Vascular; Female; Humans; Isoxazoles; Male; Piperidines; Psychotropic Drugs; Risperidone; Treatment Outcome | 1995 |
Clinical implications of clozapine discontinuation: report of an NIMH workshop.
Topics: Antipsychotic Agents; Clozapine; Drug Administration Schedule; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; United States; United States Food and Drug Administration | 1995 |
Unexpected dystonia while changing from clozapine to risperidone.
Topics: Adult; Antipsychotic Agents; Clozapine; Dystonia; Humans; Isoxazoles; Male; Piperidines; Risperidone; Schizophrenia | 1995 |
Concomitant use of thioridazine with risperidone.
Topics: Antipsychotic Agents; Drug Therapy, Combination; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia; Thioridazine | 1995 |
The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.
Topics: Adult; Akathisia, Drug-Induced; Basal Ganglia Diseases; Humans; Isoxazoles; Male; Piperidines; Receptors, Dopamine D2; Risperidone; Schizophrenia; Tomography, Emission-Computed | 1995 |
Clinical experience with risperidone.
Topics: Adolescent; Aggression; Antipsychotic Agents; Bipolar Disorder; Child; Child Behavior Disorders; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Isoxazoles; Lithium; Male; Piperidines; Risperidone | 1995 |
Is risperidone a substitute for clozapine for patients who do not respond to neuroleptics?
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Piperidines; Recurrence; Risperidone; Schizophrenia; Schizophrenia, Paranoid | 1995 |
Pharmacokinetic interaction between risperidone and clozapine.
Topics: Adult; Antipsychotic Agents; Clozapine; Drug Interactions; Drug Therapy, Combination; Humans; Isoxazoles; Male; Piperidines; Psychotic Disorders; Risperidone | 1995 |
Neuroleptic sensitivity to risperidone in Lewy body dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Basal Ganglia Diseases; Dementia; Female; Humans; Isoxazoles; Lewy Bodies; Male; Middle Aged; Parkinson Disease; Piperidines; Risperidone | 1995 |
Olanzapine, an atypical antipsychotic, increases rates of punished responding in pigeons.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Chlordiazepoxide; Clozapine; Columbidae; Conditioning, Operant; Dose-Response Relationship, Drug; Haloperidol; Isoxazoles; Male; Olanzapine; Piperidines; Pirenzepine; Punishment; Risperidone | 1995 |
Risperidone treatment of refractory acute mania.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bipolar Disorder; Female; Humans; Isoxazoles; Male; Piperidines; Risperidone; Treatment Outcome | 1995 |
The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Basal Ganglia Diseases; Behavior, Animal; Clozapine; Dopamine Antagonists; Haloperidol; Isoxazoles; Male; Mice; Piperidines; Radioligand Assay; Rats; Rats, Wistar; Risperidone; Saimiri; Serotonin Antagonists | 1995 |
Suppression of alcohol preference in rats induced by risperidone, a serotonin 5-HT2 and dopamine D2 receptor antagonist.
Topics: Alcohol Drinking; Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Rats, Wistar; Risperidone; Serotonin Antagonists | 1993 |
Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo.
Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Haloperidol; Isoxazoles; Male; Piperidines; Quinolines; Rats; Rats, Wistar; Receptors, Dopamine D1; Risperidone; Serotonin Antagonists | 1993 |
[Clinical evaluation of risperidone].
Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychotic Disorders; Risperidone | 1993 |
Neuroleptics and the immune system.
Topics: Adult; Antipsychotic Agents; Female; Humans; Immunity; Isoxazoles; Male; Middle Aged; Piperidines; Risperidone | 1993 |
Effects of atypical antipsychotic agents on social behavior in rodents.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Catalepsy; Chlorpromazine; Clozapine; Diazepam; Haloperidol; Isoxazoles; Male; Mice; Mice, Inbred Strains; Piperidines; Raclopride; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Social Behavior | 1993 |
Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection.
Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Isoxazoles; Paliperidone Palmitate; Piperidines; Pyrimidines; Regression Analysis; Risperidone | 1993 |
[Effects of risperidone on catalepsy and cerebral dopamine, serotonin and GABA metabolism in the rat: comparison with haloperidol].
Topics: Animals; Antipsychotic Agents; Brain; Catalepsy; Dopamine; gamma-Aminobutyric Acid; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Rats, Wistar; Risperidone; Serotonin | 1993 |
[A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
Topics: Animals; Antipsychotic Agents; Autoradiography; Brain; Chlorpromazine; Clozapine; Dibenzothiepins; Flupenthixol; Haloperidol; In Vitro Techniques; Isoxazoles; Male; Piperidines; Pyrimidinones; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Serotonin; Risperidone | 1993 |
Clozapine in the management of schizophrenia. Risperidone is less toxic but equally effective.
Topics: Antipsychotic Agents; Clozapine; Drug Costs; Humans; Isoxazoles; Piperidines; Risperidone; Schizophrenia | 1993 |
Determination of risperidone in plasma by high-performance liquid chromatography with electrochemical detection: application to therapeutic drug monitoring in schizophrenic patients.
Topics: Antipsychotic Agents; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Isoxazoles; Piperidines; Remoxipride; Risperidone; Schizophrenia | 1993 |
Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics.
Topics: Animals; Antipsychotic Agents; Benzamides; Brain; Clozapine; Corpus Striatum; Dopamine D2 Receptor Antagonists; In Vitro Techniques; Isoxazoles; Male; Olfactory Pathways; Piperidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Risperidone; Spiperone; Thioridazine | 1993 |
Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects.
Topics: Adult; Antipsychotic Agents; Biological Availability; Humans; Isoxazoles; Male; Models, Biological; Piperidines; Prolactin; Random Allocation; Reference Values; Risperidone | 1993 |
Pharmacological effects of zotepine and other antipsychotics on the central 5-HT2 receptors.
Topics: Animals; Antipsychotic Agents; Clozapine; Dibenzothiepins; Haloperidol; Isoxazoles; Male; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Risperidone | 1993 |
Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors.
Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Binding Sites; Dioxanes; Hippocampus; In Vitro Techniques; Isoxazoles; Male; Phentolamine; Piperazines; Piperidines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Risperidone; Spleen | 1993 |
Overdose of risperidone.
Topics: Adult; Antipsychotic Agents; Electrocardiography; Humans; Isoxazoles; Male; Piperidines; Poisoning; Risperidone; Suicide, Attempted | 1993 |
Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol.
Topics: Amphetamines; Animals; Antipsychotic Agents; Clozapine; Conditioning, Operant; Fluorobenzenes; Haloperidol; Male; Piperidines; Rats; Rats, Sprague-Dawley; Reflex, Startle; Reinforcement, Psychology; Risperidone; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
Mixed D2/5-HT2A antagonism of cocaine-induced facilitation of brain stimulation reward.
Topics: Animals; Brain; Cocaine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Piperidines; Rats; Rats, Sprague-Dawley; Reward; Risperidone; Self Stimulation; Serotonin Antagonists | 1998 |
Combination of risperidone and donepezil in Lewy body dementia.
Topics: Aged; Antipsychotic Agents; Cholinesterase Inhibitors; Dementia; Donepezil; Drug Therapy, Combination; Humans; Indans; Male; Parkinson Disease; Piperidines; Risperidone | 1998 |
Extrapyramidal side effects in a patient treated with risperidone plus donepezil.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Drug Therapy, Combination; Female; Humans; Indans; Piperidines; Risperidone | 1998 |
5-HT2A receptor blockade in patients with schizophrenia treated with risperidone or clozapine. A SPET study using the novel 5-HT2A ligand 123I-5-I-R-91150.
Topics: Adult; Basal Ganglia Diseases; Clozapine; Female; Humans; Iodine Radioisotopes; Male; Piperidines; Receptors, Serotonin; Risperidone; Schizophrenia; Serotonin Antagonists; Tomography, Emission-Computed, Single-Photon | 1998 |
M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
Topics: Animals; Antipsychotic Agents; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluorobenzenes; Male; Piperidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Reflex, Startle; Risperidone; Serotonin Antagonists; Species Specificity | 1999 |
Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo.
Topics: 3T3 Cells; Animals; Antipsychotic Agents; Benzodiazepines; Cell Line; Clozapine; Dendrites; Fluorobenzenes; Haloperidol; Mianserin; Mice; Olanzapine; Piperidines; Pirenzepine; Prefrontal Cortex; Pyramidal Cells; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recombinant Proteins; Risperidone; Ritanserin; Serotonin Antagonists; Transfection | 1999 |
The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Dopamine; Fluorobenzenes; Haloperidol; Male; Microdialysis; Nucleus Accumbens; Piperazines; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Risperidone; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium | 2000 |
Relation between cholinesterase inhibitor and Pisa syndrome.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Dopamine Antagonists; Dystonia; Female; Humans; Indans; Memory Disorders; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Posture; Psychomotor Agitation; Risperidone; Rivastigmine; Syndrome | 2000 |
Neuropharmacological profiles of a novel atypical antipsychotic, NRA0562, in rats.
Topics: Action Potentials; Animals; Antipsychotic Agents; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Immunohistochemistry; Male; Methamphetamine; Neurons; Piperidines; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Risperidone; Thiazoles | 2001 |
A behavioural pattern analysis of hypoglutamatergic mice--effects of four different antipsychotic agents.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Dizocilpine Maleate; Dopamine Antagonists; Drug Combinations; Excitatory Amino Acid Antagonists; Fluorobenzenes; Glutamic Acid; Haloperidol; Injections, Intraperitoneal; Male; Mice; Motor Activity; Piperidines; Risperidone; Serotonin Antagonists | 2001 |
Donepezil in schizophrenia--is it helpful? An experimental design case study.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cognition; Donepezil; Drug Therapy, Combination; Humans; Indans; Male; Piperidines; Risperidone; Schizophrenia; Treatment Outcome | 2001 |
Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia.
Topics: Animals; Antipsychotic Agents; Catalepsy; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Male; Motor Activity; Piperidines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Serotonin; Reflex, Startle; Risperidone; Schizophrenia; Serotonin Antagonists; Social Behavior; Tosyl Compounds | 2002 |
Donepezil management of schizophrenia with associated dementia.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Comorbidity; Dementia; Donepezil; Drug Therapy, Combination; Female; Humans; Indans; Mental Status Schedule; Middle Aged; Nootropic Agents; Parkinson Disease; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2002 |
Antipsychotic profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562) in rats.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Clozapine; Dose-Response Relationship, Drug; Haloperidol; Male; Piperidines; Rats; Rats, Wistar; Risperidone; Thiazoles | 2002 |
Extrapyramidal side-effect due to drug combination of risperidone and donepezil.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Basal Ganglia Diseases; Donepezil; Drug Interactions; Drug Therapy, Combination; Female; Humans; Indans; Nootropic Agents; Piperidines; Risperidone | 2002 |
In vitro and in vivo pharmacological profile of 5-[2-[4-(6-fluoro-1H-indole-3-yl)piperidin-1-yl]ethyl]-4-(4-fluorophenyl)thiazole-2-carboxylic acid amide (NRA0562), a novel and putative atypical antipsychotic.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Central Nervous System Stimulants; Clozapine; Humans; Male; Methamphetamine; Motor Activity; Piperidines; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Receptors, Dopamine; Receptors, Drug; Receptors, Serotonin; Risperidone; Stereotyped Behavior; Thiazoles | 2002 |
In vitro and in vivo pharmacological profile of 4-(4-fluorobenzylidene)-1-[2-[5-(4-fluorophenyl)-1H-pyrazol-4-yl] ethyl] piperidine (NRA0161).
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Binding, Competitive; Blood Pressure; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Humans; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperidines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Receptors, Dopamine; Receptors, Drug; Receptors, Serotonin; Risperidone; Stereotyped Behavior | 2002 |
alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brimonidine Tartrate; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Cyclic AMP; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Humans; Isoxazoles; Norepinephrine; Olanzapine; Piperazines; Piperidines; Pirenzepine; Quetiapine Fumarate; Quinolones; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Risperidone; Thiazoles; Transfection; Yohimbine | 2003 |
'Awakenings' in demented patients.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Awareness; Cholinesterase Inhibitors; Delusions; Depressive Disorder; Donepezil; Female; Humans; Indans; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Sick Role | 2003 |
Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig.
Topics: Animals; Antipsychotic Agents; Bepridil; Blood Pressure; Calcium Channel Blockers; Calcium Channels, L-Type; Cisapride; Delayed Rectifier Potassium Channels; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Gastrointestinal Agents; Guinea Pigs; Heart Rate; Histamine H1 Antagonists; Humans; In Vitro Techniques; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Piperidines; Potassium Channels, Voltage-Gated; Pyridines; Risperidone; Terfenadine; Verapamil | 2004 |
Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan.
Topics: Acoustic Stimulation; Animals; Dopamine Antagonists; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Histamine Antagonists; Imidazoles; Inhibition, Psychological; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Piperidines; Receptors, Histamine H3; Reflex, Startle; Risperidone; Species Specificity | 2004 |
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; DNA, Complementary; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Lisuride; Piperazines; Piperidines; Quinolones; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Risperidone; Transfection; Tritium | 2005 |
Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Benzofurans; Brain Chemistry; Cataplexy; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Synergism; Haloperidol; Histamine; Histamine Antagonists; Imidazoles; Ketoconazole; Male; Metabolic Clearance Rate; Piperidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Histamine H3; Risperidone; Schizophrenia | 2005 |
Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation.
Topics: Animals; Anisoles; Antipsychotic Agents; Benzazepines; Butaclamol; Caspase Inhibitors; Cell Death; Cells, Cultured; Chlorpromazine; Clozapine; Domperidone; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Ginkgo biloba; Haloperidol; Hippocampus; Indans; Isoxazoles; Neurons; Neuroprotective Agents; Peptides; Piperidines; Plant Extracts; Propylamines; Raclopride; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Remoxipride; Risperidone; Sulpiride | 2006 |
Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Clozapine; Conditioning, Psychological; Dioxoles; Drug Synergism; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperidines; Pyrimidines; Rats; Rats, Wistar; Receptors, AMPA; Risperidone; Serine; Stereoisomerism | 2006 |
Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Dopamine; Dronabinol; Haloperidol; Inhibition, Psychological; Male; Mice; Nucleus Accumbens; Piperidines; Prefrontal Cortex; Pyrazoles; Reflex, Startle; Rimonabant; Risperidone; Rotarod Performance Test | 2006 |
[Risperidone and cerebrovascular adverse effects in elderly patients with dementia].
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cerebrovascular Disorders; Cholinesterase Inhibitors; Dementia, Vascular; Donepezil; Female; Galantamine; Humans; Indans; Male; Piperidines; Risperidone | 2006 |
ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Brain Chemistry; Catalepsy; Dizocilpine Maleate; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Haloperidol; Head Movements; Male; Mice; Mice, Inbred Strains; Motor Activity; Piperidines; Prolactin; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Urea | 2007 |
[Amnesic syndrome following lesion of the fornix or does reversible Korsakow's syndrome exist?].
Topics: Amnesia, Anterograde; Citalopram; Donepezil; Female; Fornix, Brain; Humans; Indans; Intracranial Aneurysm; Korsakoff Syndrome; Middle Aged; Neurosurgical Procedures; Nootropic Agents; Piperidines; Risperidone; Rupture, Spontaneous; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2007 |
Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.
Topics: Aconitine; Acoustic Stimulation; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Animals, Outbred Strains; Apomorphine; Behavior, Animal; Cholinesterase Inhibitors; Dizocilpine Maleate; Donepezil; Dose-Response Relationship, Drug; Galantamine; Indans; Male; Mecamylamine; Mice; Neural Inhibition; Nicotinic Antagonists; Piperidines; Receptors, Nicotinic; Reflex, Startle; Risperidone; Social Isolation | 2008 |
Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered.
Topics: Animals; Behavior, Animal; Clozapine; Conditioning, Psychological; Cycloserine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Emotions; Fluorobenzenes; Glycine; Glycine Agents; Inhibition, Psychological; Male; Piperidines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Stress, Psychological; Thirst; Treatment Outcome | 2008 |
Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antipsychotic Agents; Behavior; Benzodiazepines; Cognition; Data Interpretation, Statistical; Dibenzothiazepines; Donepezil; Endpoint Determination; Female; Galantamine; Humans; Indans; Long-Term Care; Male; Neuropsychological Tests; Nootropic Agents; Olanzapine; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Retrospective Studies; Risperidone; Rivastigmine; Treatment Outcome | 2007 |
Neuroleptic malignant syndrome and catatonia in a patient with dementia.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Chlorpromazine; Cholinesterase Inhibitors; Cognition Disorders; Creatine Kinase; Dementia; Disease Progression; Donepezil; Female; Humans; Indans; Lorazepam; Muscle Rigidity; Neuroleptic Malignant Syndrome; Olanzapine; Piperidines; Recurrence; Risperidone | 2008 |
An odd manifestation of the Capgras syndrome: loss of familiarity even with the sexual partner.
Topics: Aged; Amnesia; Antipsychotic Agents; Atrophy; Brain; Capgras Syndrome; Donepezil; Hallucinations; Humans; Indans; Male; Memory; Movement Disorders; Neuropsychological Tests; Nootropic Agents; Parkinsonian Disorders; Piperidines; Recognition, Psychology; Risperidone; Sexual Behavior; Spouses; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Effect of sertindole on extracellular dopamine, acetylcholine, and glutamate in the medial prefrontal cortex of conscious rats: a comparison with risperidone and exploration of mechanisms involved.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Dopamine; Dopamine D2 Receptor Antagonists; Drug Synergism; Extracellular Space; Fluorobenzenes; Glutamic Acid; Haloperidol; Imidazoles; Indoles; Male; Microdialysis; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Risperidone; Serotonin 5-HT2 Receptor Antagonists | 2009 |
Drug-induced sialorrhoea and excessive saliva accumulation.
Topics: Antipsychotic Agents; Benzodiazepines; Cholinesterase Inhibitors; Clozapine; Deglutition Disorders; Donepezil; Galantamine; Humans; Hypnotics and Sedatives; Indans; Phenylcarbamates; Pilocarpine; Piperidines; Quality of Life; Risperidone; Rivastigmine; Sialorrhea | 2009 |
Case of delirium complicated with pneumonia that improved with blonanserin administration.
Topics: Aged; Antipsychotic Agents; Delirium; Humans; Male; Piperazines; Piperidines; Pneumonia; Psychiatric Status Rating Scales; Psychomotor Agitation; Risperidone | 2010 |
Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Brain; Dopamine; Male; Microdialysis; Norepinephrine; Piperazines; Piperidines; Prefrontal Cortex; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Risperidone; Telemetry | 2011 |
Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Catalepsy; Drug Synergism; Glutamic Acid; Glycine Plasma Membrane Transport Proteins; Haloperidol; Male; Membrane Potentials; Olanzapine; Oxadiazoles; Piperidines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, AMPA; Risperidone; Synaptic Transmission; Tetrahydronaphthalenes | 2012 |
Publication bias in antipsychotic trials: an analysis of efficacy comparing the published literature to the US Food and Drug Administration database.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Databases, Factual; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Publication Bias; Pyrimidines; Quetiapine Fumarate; Quinolones; Risperidone; United States; United States Food and Drug Administration | 2012 |
Transmural dispersion of repolarization as a preclinical marker of drug-induced proarrhythmia.
Topics: Action Potentials; Animals; Bepridil; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Ether-A-Go-Go Potassium Channels; Heart Conduction System; Humans; In Vitro Techniques; Long QT Syndrome; Piperidines; Potassium Channel Blockers; Pyridines; Risk Assessment; Risperidone; Time Factors; Torsades de Pointes; Toxicity Tests; Verapamil; Voltage-Sensitive Dye Imaging | 2012 |
Blonanserin, a novel atypical antipsychotic agent not actively transported as substrate by P-glycoprotein.
Topics: Animals; Antipsychotic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Brain; Cell Line, Transformed; Humans; Isoxazoles; LLC-PK1 Cells; Mice; Mice, Inbred Strains; Mice, Knockout; Paliperidone Palmitate; Piperazines; Piperidines; Pyrimidines; Risperidone; Swine | 2012 |
Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Data Interpretation, Statistical; Dizocilpine Maleate; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fluorobenzenes; Haloperidol; Male; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reflex, Startle; Risperidone; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sulfonamides; Thiophenes | 2014 |
Blonanserin improved dystonia induced by risperidone or olanzapine in two patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dystonia; Female; Humans; Olanzapine; Piperazines; Piperidines; Risperidone; Schizophrenia; Young Adult | 2014 |
Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice.
Topics: Animals; Antipsychotic Agents; Autistic Disorder; Disease Models, Animal; Fluorobenzenes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Piperidines; Probability Learning; Receptor, Serotonin, 5-HT2A; Reversal Learning; Risperidone; Serotonin 5-HT2 Receptor Antagonists | 2014 |
Evaluation of human D-amino acid oxidase inhibition by anti-psychotic drugs in vitro.
Topics: Antipsychotic Agents; D-Amino-Acid Oxidase; Enzyme Activation; Humans; Piperazines; Piperidines; Risperidone | 2014 |
Donepezil and the alpha-7 agonist PHA 568487, but not risperidone, ameliorate spatial memory deficits in a subchronic MK-801 mouse model of cognitive impairment in schizophrenia.
Topics: Acetylcholinesterase; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antipsychotic Agents; Aza Compounds; Cholinesterase Inhibitors; Cognition Disorders; Dioxins; Disease Models, Animal; Dizocilpine Maleate; Donepezil; Indans; Male; Mice, Inbred C57BL; Nicotinic Agonists; Nootropic Agents; Piperidines; Risperidone; Schizophrenia; Schizophrenic Psychology; Spatial Memory | 2014 |
Blonanserin ameliorated the tendency toward QTc prolongation associated with risperidone in a patient with schizophrenia.
Topics: Adult; Antipsychotic Agents; Female; Humans; Long QT Syndrome; Piperazines; Piperidines; Risperidone; Schizophrenia | 2015 |
Challenges in the management of delirium: a case of augmentation with donepezil following inadequate response and adverse effects with risperidone.
Topics: Anticholinergic Syndrome; Antiparkinson Agents; Antipsychotic Agents; Biperiden; Burns; Cholinesterase Inhibitors; Delirium; Diagnosis, Differential; Donepezil; Drug Administration Routes; Drug Synergism; Humans; Indans; Male; Middle Aged; Muscle Rigidity; Physostigmine; Piperidines; Risperidone; Treatment Outcome | 2015 |
The serotonin 5-HT₁A receptor agonist tandospirone improves executive function in common marmosets.
Topics: Animals; Antipsychotic Agents; Callithrix; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Executive Function; Haloperidol; Isoindoles; Male; Piperazines; Piperidines; Psychological Tests; Psychotropic Drugs; Pyrimidines; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Risperidone; Serotonin 5-HT1 Receptor Agonists | 2015 |
Differential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations.
Topics: Animals; Cannabinoid Receptor Antagonists; Central Nervous System Agents; Cerebral Cortex; Cholecystokinin; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Gene Expression; Haloperidol; Immunohistochemistry; Male; Methylphenidate; Mice, Knockout; Neurons; Parvalbumins; Peptide Fragments; Piperidines; Prepulse Inhibition; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Adrenergic, alpha-2; Risperidone; Time Factors | 2015 |
Nicotinic α7 and α4β2 agonists enhance the formation and retrieval of recognition memory: Potential mechanisms for cognitive performance enhancement in neurological and psychiatric disorders.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Benzamides; Bridged Bicyclo Compounds; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Indans; Locomotion; Mental Recall; Nicotine; Nicotinic Agonists; Piperidines; Rats; Recognition, Psychology; Retention, Psychology; Risperidone | 2016 |
Serotonin 5-HT
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antipsychotic Agents; Brain Waves; Cortical Synchronization; Dopamine Agonists; Dopamine Antagonists; Electroencephalography; Fluorobenzenes; Gamma Rhythm; Haloperidol; Hippocampus; Locomotion; Mice; Neural Pathways; Piperazines; Piperidines; Prefrontal Cortex; Pyridines; Quinpirole; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Risperidone; Serotonin Antagonists; Serotonin Receptor Agonists | 2019 |
Discovery of a new class of multi-target heterocycle piperidine derivatives as potential antipsychotics with pro-cognitive effect.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Cognition; Dopamine; Drug Design; Humans; Hyperprolactinemia; Mice; Models, Animal; Movement; Piperidines; Protein Binding; Receptors, Histamine H3; Risperidone; Serotonin; Structure-Activity Relationship; Weight Gain | 2021 |